Author:
Martin D.,Schreckenbach T.,Ziegler P.,Filmann N.,Kalinauskaite G.,Tinhofer I.,Budach V.,Gani C.,Zips D.,Schimek-Jasch T.,Schäfer H.,Grosu A.L.,Thomas E.,Krause M.,Dapper H.,Combs S.,Hoffmann C.,Stuschke M.,Walter F.,Belka C.,Kurth I.,Hadiwikarta W.W,Baumann M.,Rödel C.,Fokas E.
Subject
Radiology, Nuclear Medicine and imaging,Oncology,Hematology
Reference45 articles.
1. Deshmukh AA, Suk R, Shiels MS, Sonawane K, Nyitray AG, Liu Y, et al. Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015. JNCI J Natl Cancer Inst n.d. 10.1093/jnci/djz219.
2. Combined therapy for cancer of the anal canal: a preliminary report;Nigro;Dis Colon Rectum,1974
3. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial;James;Lancet Oncol,2013
4. Long-term update of US GI intergroup RTOG 98–11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin;Gunderson;J Clin Oncol,2012
5. Anal squamous cell carcinoma - State of the art management and future perspectives;Martin;Cancer Treat Rev,2018